Cerebral blood flow measured by arterial spin labeling MRI as a preclinical marker of alzheimer's disease

Journal of Alzheimer's Disease

Volumn 42, Issue , 2014, Pages S411-S419

  Wierenga, Christina E ^a,b   Hays, Chelsea C ^a   Zlatar, Zvinka Z ^a,b  

^a VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer's disease; arterial spin labeling; cerebral blood flow; cerebrovascular disorders; cognition; mild cognitive impairment; neuroimaging; neurovascular dysfunction; perfusion

Indexed keywords

APOLIPOPROTEIN E; SPIN LABELING;

ALZHEIMER DISEASE; ANTERIOR CINGULATE; ARTERIAL SPIN LABELING; BLOOD FLOWMETRY; BLOOD OXYGENATION; BRAIN BLOOD FLOW; BRAIN PERFUSION; FAMILY HISTORY; HIPPOCAMPUS; HUMAN; LINGUAL GYRUS; MIDDLE TEMPORAL GYRUS; MILD COGNITIVE IMPAIRMENT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARIETAL LOBE; POSTERIOR CINGULATE; PRECUNEUS; REVIEW; SPIN LABELING; BLOOD FLOW VELOCITY; BRAIN CIRCULATION; ELECTRON SPIN RESONANCE; PATHOPHYSIOLOGY; PHYSIOLOGY;

ALZHEIMER DISEASE; BLOOD FLOW VELOCITY; CEREBROVASCULAR CIRCULATION; ELECTRON SPIN RESONANCE SPECTROSCOPY; HUMANS; SPIN LABELS;

EID: 84908212297     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-141467     Document Type: Review

References (63)

1. James BD, Leurgans SE, Hebert LE, Scherr PA,Yaffe K, BennettDA( 2014) Contribution of Alzheimer disease to mortality in the United States. Neurology 82, 1045-1050.
2. Jack CR Jr., Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW, Petersen RC, Tr ojanowski JQ (2010) Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol 9, 119-128.
3. Ewers M, Mielke MM, Hampel H (2010) Blood-based biomarkers of microvascular pathology in Alzheimer's disease. Exp Gerontol 45, 75-79.
4. Kelleher RJ, Soiza RL (2013) Evidence of endothelial dysfunction in the development of Alzheimer's disease: Is Alzheimer's a vascular disorder? Am J Cardiovasc Dis 3, 197-226.
5. Popa-Wagner A, Buga A-M, Popescu B, Muresanu D (2013) Vascular cognitive impairment, dementia, aging and energy demand. A vicious cycle. J Neural Transm. doi: 10.1007/s00702-013-1129-3
6. Zlokovic BV (2011) Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nat Rev Neurosci 12, 723-738.
7. Iadecola C (2004) Neurovascular regulation in the normal brain and in Alzheimer's disease. Nat Rev Neurosci 5, 347-360.
8. Ruitenberg A, den Heijer T, Bakker SLM, van Swieten JC, Koudstaal PJ, Hofman A, Breteler MMB (2005) Cerebral hyp operfusion and clinical onset of dementia: The Rotterdam Study. Ann Neurol 57, 789-794.
9. Smith CD, Andersen AH, Kryscio RJ, Schmitt FA, Kindy MS, Blonder LX, Avison MJ (1999) Alter ed brain activation in cognitively intact individuals at high risk for Alzheimer's disease. Neurology 53, 1391-1396.
10. Dorr A, Sahota B, Chinta LV, Brown ME, Lai AY, Ma K, Hawkes CA, Mc Laurin J, Stefanovic B (2012) Amyloid-dependent compromise of microvascular structure and function in a model of Alzheimer's disease. Brain J Neurol 135, 3039-3050.
11. Niwa K, Kazama K, Younkin L , Younkin SG, Carlson GA, Iadecola C (2002) Cerebrovascular autoregulation is profoundly impaired in mice overexpressing amyloid precursor protein. Am J Physiol Heart Circ Physiol 283, H315-H323.
12. Den Abeelen ASSM, Lagro J, van Beek AHEA, Claassen JAHR(2014) Impaired cerebral autoregulation and vasomotor reactivity in sporadic Alzheimer's disease. Curr Alzheimer Res 11, 11-17.
13. Bell RD, Winkler EA, Sagare AP, Singh I, LaRue B, Deane R, Zlokovic BV (2010) Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging. Neuron 68, 409-427.
14. Bell RD, Winkler EA, Singh I, Sagare AP, Deane R, Wu Z, HoltzmanDM,Betsholtz C, Armulik A, Sallstrom J, Berk BC, Zlokovic BV (2012) Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. Nature 485, 512-516.
15. Elali A, Thá riault P, Práfontaine P, Rivest S (2013) Mild chronic cerebral hypoperfusion induces neurovascular dysfunction, triggering peripheral beta-Amylo id brain entry and aggregation. Acta Neuropathol Commun 1, 75.
16. Liu TT, BrownGG(2007) Measurement of cerebral perfusion with arterial spin labeling: Part 1. Methods J Int Neuropsychol Soc 13, 517-525.
17. Parkes LM, Rashid W, Chard DT, Tofts PS (2004) Normal cerebral perfusion measurements using arterial spin labeling: Reproducibility, stability, and age and gender effects. Magn Reson Med 51, 736-743.
18. Asllani I, Habeck C, Scarmeas N, Borogovac A, Brown TR, Stern Y (2008) Multivariate and univariate analysis of continuous arterial spin labeling perfusion MRI in Alzheimer's disease. J Cereb Blood Flow Metab 28, 725-736.
19. Alsop DC, Detre JA, Grossman M (2000) Assessment of cerebral blood flow in Alzheimer's disease by spin-labeled magnetic resonance imaging. Ann Neurol 47, 93-100.
20. Dai W, Lopez OL, Carmichael OT, Becker JT, Kuller LH, Gach H M (2009) Mild cognitive impairment and Alzheimer disease: Patterns of altered cerebral blood flow at MR imaging. Radiology 250, 856-866.
21. Johnson NA, Jahng G-H, Weiner MW, Miller BL, Chui HC, Jagust WJ, Gorno-Tempini ML, Schuff N (2005) Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: Initial experience. Radiology 234, 851-859.
22. Lacalle-Aurioles M, Mateos-Párez JM, Guzmán-De-Villoria JA, Olazarán J, Cruz-Orduña I, Alemán-Gómez Y, Martino M-E, Desco M (2014) Cerebral blood flow is an earlier indicator of p erfusion abnormalities than cerebral blood volume in Alzheimer's disease. J Cereb Blood Flow Metab 34, 654-659.
23. Wierenga CE, Dev SI, Shin DD, Clark LR, Bangen KJ, Jak AJ, Rissman RA, Liu TT, Salmon DP, Bondi MW (2012) Effect of mild cognitive impairment and APOE genotype on resting cerebral blood flow and its association with cognition. J Cereb Blood Flow Metab 32, 1589-1599.
24. Hu WT, Wang Z, Lee VM-Y, Trojanowski JQ, Detre JA, Grossman M (2010) Distinct cerebral perfusion patterns in FTLD and AD. Neurology 75, 881-888.
25. Alsop DC, Casement M, de Bazelaire C, Fong T, Press DZ (2008) Hippocampal hyperperfusion in Alzheimer's disease. Neuroimage 42, 1267-1274.
26. Braak H, Braak E (1991) Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections. Brain Pathol 1, 213-216.
27. Le Heron CJ, Wright SL, Melzer TR, Myall DJ, Macaskill MR, Livingston L, Keenan RJ, Watts R, Dalrymple-Alford JC, An derson TJ (2014) Comparing cerebral perfusion in Alzheimer's disease and Parkinson's disease dementia: An ASL-MRI study. J Cereb Blood Flow Metab 34, 964-970.
28. Iacono D, O'Brien R, Resnick SM, Zo nderman AB, Pletnikova O, Rudow G, An Y, West MJ, Crain B, Troncoso JC (2008) Neuronal hypertrophy in asymptomatic Alzheimer disease. J Neuropathol Exp Neurol 67, 578-589.
29. Sandson TA, O'Conn or M, Sperling RA, Edelman RR, Warach S (1996) Noninvasive perfusion MRI in Alzheimer's disease: A preliminary report. Neurology 47, 1339-1342.
30. Bron EE, Steketee RME, Houston GC, Oliver RA, Achterberg HC, Loog M, van Swieten JC, Hammers A, Niessen WJ, Smits M, Klein S, for the Alzheimer's Disease Neuroimaging, Initiative (2014) Diagnostic classification of arterial spin labeling and structura l MRI in presenile early stage dementia. Hum Brain Mapp 35, 4916-4931.
31. Jarvik L, LaRue A, Blacker D, Gatz M, Kawas C, McArdle JJ, Morris JC, Mortimer JA, Ringman JM, Ercoli L, F reimer N, Gokhman I, Manly JJ, Plassman BL, Rasgon N, Roberts JS, Sunderland T, Swan GE,Wolf PA, Zonderman AB (2008) Children of persons with Alzheimer disease: What does the future hold? Alzheimer Dis Assoc Disord 22, 6-20.
32. Corder EH,Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, SmallGW, Roses AD, Haines JL, Pericak-Vance MA 1993 Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families Science 261, 921-923.
33. Tiraboschi P, Hansen LA, Masliah E, Alford M, Thal LJ, Corey-Bloom J (2004) Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease. Neurology 62, 1977-1983.
34. Yip AG, McKee AC, Green RC , Wells J, Young H, Cupples LA, Farrer LA (2005) APOE, vascular pathology, and the AD brain. Neurology 65, 259-265.
35. Bangen KJ, Restom K, Liu TT,Wierenga CE, Jak AJ, Salmo n DP, Bondi MW (2012) Assessment of Alzheimer's disease risk with functional magnetic resonance imaging: An arterial spin labeling study. J Alzheimers Dis 31(Suppl 3), S59-S74.
36. Wierenga CE, Clark LR , Dev SI, Shin DD, Jurick SM, Rissman RA, Liu TT, Bondi MW (2013) Interaction of age and APOE genotype on cerebral blood flow at rest. J Alzheimers Dis 34, 921-935.
37. Thambisetty M, Beason-Held L, An Y, Kraut MA, Resnick SM (2010) APOE epsilon4 genotype and longitudinal changes in cerebral blood flow in normal aging. Arch Neurol 67, 93-98.
38. Kim SM, Kim MJ, Rhee HY, Ryu C-W , Kim EJ, Petersen ET, JahngG-H(2013) Regional cerebral perfusion in patients with Alzheimer's disease and mild cognitive impairment: Effect of APOE epsilon4 allele. Neuroradiology 55, 25-34.
39. Okonkw o OC, Xu G, Oh JM, Dowling NM, Carlsson CM, Gallagher CL, Birdsill AC, Palotti M, Wharton W, Hermann BP, Larue A, Bendlin BB, Rowley HA, Asthana S, Sager MA, Johnson SC (2014) Cerebral blood flow is diminished in asymptomatic middle-Aged adults with maternal history of Alzheimer's disease. Cereb Cortex 24, 978-988.
40. Fleisher AS, Podraza KM, Bangen KJ, Taylor C, Sherzai A, Sidhar K , Liu TT, Dale AM, Buxton RB (2009) Cerebral perfusion and oxygenation differences in Alzheimer's disease risk. Neurobiol Aging 30, 1737-1748.
41. Mattsson N, Tosun D, Insel PS, Simo nson A, Jack CR Jr., Beckett LA, Donohue M, Jagust W, Schuff N, Weiner MW, Alzheimer's Disease Neuroimaging, Initiative (2014) Association of brain amyloid-with cerebral perfusion and structure in Alzheimer's disease and mild cognitive impairment. Brain J Neurol 137, 1550-1561.
42. PetersenRC(2004) Mild cognitive impairment as a diagnostic entity. J Intern Med 256, 183-194.
43. Alexopoulos P, Sorg C, Förschler A, Grimmer T, Skokou M, Wohlschläger A, Perneczky R, Zimmer C, Kurz A, Preibisch C (2012) Perfusion abnormalities in mild cognitive impairment and mild dementia in Alzheimer's disease measured b y pulsed arterial spin labeling MRI. Eur Arch Psychiatry Clin Neurosci 262, 69-77.
44. Xu G, Antuono PG, Jones J, Xu Y, Wu G, Ward D, Li S-J (2007) Perfusion fMRI detects deficits in regional CBF during memory-encoding tasks inMCIsubjects. Neurology 69, 1650-1656.
45. Yoon HJ, Park KW, Jeong YJ, Kang D-Y (2012) Correlation between neuropsychological tests and hypoperfusion in M CI patients: Anatomical labeling using xjView and Talairach Daemon software. Ann Nucl Med 26, 656-664.
46. Ding B, Ling H-W, Zhang Y, Huang J, Zhang H,Wang T, Yan FH (2014) Pattern of cerebr al hyperperfusion in Alzheimer's disease and amnestic mild cognitive impairment using voxelbased analysis of 3D arterial spin-labeling imaging: Initial experience. Clin Interv Aging 9, 493-500.
47. Chao LL, Pa J, Duarte A, Schuff N, Weiner MW, Kramer JH, Miller BL, Freeman KM, Johnson JK (2009) Patterns of cerebral hypoperfusion in amnestic and dysexecutive MCI. Alzheimer Dis Assoc Disor d 23, 245-252.
48. Ostergaard L, Aamand R, Gutierrez-Jimenez E, Ho YC, Blicher JU, Madsen SM, Nagenthiraja K, Dalby RB, Drasbek KR, Moller A, Braendgaard H, Mouridsen K, Je spersen SN, Jensen MS, West MJ (2013) The capillary dysfunction hypothesis of Alzheimer's disease. Neurobiol Aging 34, 1018-1031.
49. Beason-Held LL, Goh JO, An Y, Kraut MA, O'Brien RJ, Ferrucci L, Resnick SM (2013) Changes in brain function occur years before the onset of cognitive impairment. J Neurosci 33, 18008-18014.
50. Chao LL, Buckley ST, Kornak J, Schuff N,Madison C, Yaffe K, Miller BL, Kramer JH,WeinerMW(2010) ASL perfusion MRI predicts cognitive decline and conversion from MCI to dementia. Alzheimer Dis Assoc Disord 24 , 19-27.
51. Borroni B, Anchisi D, Paghera B, Vicini B, Kerrouche N, Garibotto V, Terzi A, Vignolo LA, Di Luca M, Giubbini R, Padovani A, Perani D (2006) Combined 99mTc-ECD SPECT and neuropsychological studies in MCI for the assessment of conversion to AD. Neurobiol Aging 27, 24-31.
52. Park KW, Yoon HJ, Kang D-Y, Kim BC, Kim S, Kim JW (2012) Regional cerebral blood flow differences in patients with mild cognitive impairment between those who did and did not develop Alzheimer's disease. Psychiatry Res 203, 201-206.
53. Caroli A,Testa C,.Geroldi C,Nobili F,Barnden LR,Guerra UP,Bonetti M,Frisoni GB 2007 Cerebral perfusion correlates of conversion to Alzheimer's disease in amnestic mild cognitive impairment J Neurol 254, 1698-1707.
54. Bang en K, Nation D, Clark L, Harmell A,Wierenga C,Dev S, Delano-Wood L, Zlatar Z, Salmon D, Liu T, Bondi M (2014) Interactive effects of vascular risk burden and advanced age on cerebral blood flow. Front Aging Neuros ci 6, 159.
55. Alsop DC, Dai W, Grossman M, Detre JA (2010) Arterial spin labeling blood flow MRI: Its role in the early characterization of Alzheimer's disease. J Alzheimers Dis 20, 871-880.
56. Chen Y, Wolk DA, Reddin JS, Korczykowski M, Martinez PM, Musiek ES, Newberg AB, Julin P, Arnold SE, Greenberg JH, Detre JA (2011) Voxel-level comparison of arterial spinlabeled p erfusion MRI and FDG-PET in Alzheimer disease. Neurology 77, 1977-1985.
57. Takahashi H, Ishii K, Hosokawa C, Hyodo T, Kashiwagi N, Matsuki M, Ashikaga R, Murakami T (2014) Clinical applicat ion of 3D arterial spin-labeled brain perfusion imaging for Alzheimer disease: Comparison with brain perfusion SPECT. Am J Neuroradiol 35, 906-911.
58. Schuff N, Matsumoto S, Kmiecik J, Studholme C, Du A, Ezekiel F, Miller BL, Kramer JH, Jagust WJ, Chui HC, WeinerMW(2009) Cerebral blood flow in ischemic vascular dementia and Alzheimer's disease, measured by arterial spinlabeling magnetic resonance imaging. Alzheimers Dement 5, 454-462.
59. Firbank MJ, He J, Blamire AM, Singh B, Danson P, Kalaria RN, O'Brien JT (2011) Cerebral blood flow by arterial spin labeling in poststroke dementia. Neurology 76, 1478-1484.
60. Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR Jr., Kaye J, Montine TJ, Park DC, Reiman EM, Rowe CC, Siemers E, Stern Y, Yaffe K, Carrillo MC, Thies B, Morrison-Bogorad M, Wagster MV, Phelps CH (2011) Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Associat ion workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7, 280-292.
61. Biomarkers Definitions Working, Group (2001) Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework. Clin Pharmacol Ther 69, 89-95.
62. Zlatar ZZ, Wieren ga CE, Bangen KJ, Liu TT, Jak AJ (2014) Increased hippocampal blood flow in sedentary older adults at genetic risk for Alzheimer's disease. J Alzheimers Dis 41, 809-817.
63. Chapman SB, Aslan S, Spence JS, Defina LF, Keebler MW, Didehbani N, Lu H (2013) Shorter term aerobic exercise improves brain, cognition, and cardiovascular fitness in aging. Front Aging Neurosci 5, 75.